Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B

被引：0
|
作者：
Buti, M
Casado, MA
Calleja, JL
Salmerón, J
Aguilar, J
Rueda, M
Esteban, R
机构：
[1] Hosp Gen Univ Vall Hebron, Barcelona, Spain
[2] Hosp Puerto Hierro, Madrid, Spain
[3] Hosp Clin San Cecilio, Granada, Spain
[4] Hosp Virgen Rocio, Seville, Spain
[5] Gilead Sci Inc, Madrid, Spain
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：354A / 354A
页数：1
相关论文
共 50 条
  • [1] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [2] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [3] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
  • [4] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [5] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
    Hadziyannis, Stephanos J.
    Tassopoulos, Nicolaos C.
    Heathcote, E. Jenny
    Chang, Ting-Tsung
    Kitis, George
    Rizzetto, Mario
    Marcellin, Patrick
    Lik, Seng Gee
    Goodman, Zachary
    Ma, Jia
    Brosgart, Carol L.
    Eorroto-Esoda, Katyna
    Arterburn, Sarah
    Chuck, Steven L.
    [J]. GASTROENTEROLOGY, 2006, 131 (06) : 1743 - 1751
  • [6] Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
    Rapti, Irene N.
    Dimou, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    [J]. HEPATOLOGY, 2006, 44 (04) : 558A - 559A
  • [7] Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 172 - 172
  • [8] Long-term antiviral therapy with lamivudine (LAM) and salvage adefovir dipivoxil (ADV) improves the outcome of patients with HBeAg-NEGATIVE chronic hepatitis B (CHBe-)
    Papatheodoridis, GV
    Dimou, E
    Dimakopoulos, K
    Manolakopoulos, S
    Rapti, I
    Kitis, G
    Tzourmakliotis, D
    Manesis, E
    Hadziyannis, SJ
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 189 - 189
  • [9] Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    Manolakopoulos, Spilios
    Striki, Athanasia
    Deutsch, Melanie
    Mela, Maria
    Ketikoglou, Ioannis
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    [J]. LIVER INTERNATIONAL, 2011, 31 (10) : 1525 - 1532
  • [10] Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, P
    Vigano, M
    Manenti, E
    Lunghi, G
    Iavarone, M
    Del Ninno, E
    Colombo, M
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 182 - 182
12345